IRIS
PREVITI, Santo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.252
NA - Nord America 1.769
AS - Asia 1.500
SA - Sud America 479
AF - Africa 51
OC - Oceania 4
Totale 7.055
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.767
US - Stati Uniti d'America 1.713
SG - Singapore 625
IT - Italia 409
BR - Brasile 403
CN - Cina 381
IE - Irlanda 300
HK - Hong Kong 208
SE - Svezia 180
PL - Polonia 178
VN - Vietnam 110
FR - Francia 107
DE - Germania 78
AT - Austria 71
GB - Regno Unito 50
IN - India 35
MX - Messico 31
BE - Belgio 29
AR - Argentina 26
FI - Finlandia 23
IQ - Iraq 23
BD - Bangladesh 20
NL - Olanda 19
CA - Canada 18
MA - Marocco 15
TR - Turchia 14
CO - Colombia 12
UZ - Uzbekistan 12
ID - Indonesia 11
PK - Pakistan 11
ZA - Sudafrica 11
EC - Ecuador 10
UA - Ucraina 9
VE - Venezuela 8
ES - Italia 7
PY - Paraguay 7
JP - Giappone 6
CL - Cile 5
DZ - Algeria 5
LT - Lituania 5
SA - Arabia Saudita 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
KE - Kenya 4
PE - Perù 4
AU - Australia 3
GE - Georgia 3
KR - Corea 3
KW - Kuwait 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IL - Israele 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
TZ - Tanzania 1
Totale 7.055
Salva come PNG Salva come JPEG
Città #
Moscow 538
Singapore 348
Ashburn 312
Dublin 300
Chandler 251
Hong Kong 208
Warsaw 176
Messina 156
Nyköping 148
Beijing 121
Dallas 115
San Jose 63
Vienna 62
Princeton 50
Los Angeles 41
Ann Arbor 38
Lauterbourg 38
The Dalles 38
Ho Chi Minh City 35
Medford 34
Redondo Beach 33
Des Moines 31
São Paulo 26
Guangzhou 24
Hanoi 23
Frankfurt am Main 21
New York 21
Aversa 19
Santa Clara 19
Jacksonville 18
Brussels 17
Rome 17
Dearborn 16
Montpellier 16
Munich 16
Brasília 15
Orem 15
Cambridge 14
Modica 14
Buffalo 13
Houston 12
San Mateo 12
Tashkent 12
Tianjin 12
Amsterdam 11
Baghdad 11
Belo Horizonte 10
Chennai 10
Council Bluffs 10
Mexico City 10
Montreal 10
Rio de Janeiro 10
Shenzhen 10
Bari 9
Boston 9
Curitiba 9
Denver 9
Jinan 9
London 9
San Francisco 9
Brooklyn 8
Catania 8
Ixelles-Elsene 8
Stockholm 8
Bexley 7
Helsinki 7
Phoenix 7
Siderno 7
Wilmington 7
Atlanta 6
Berlin 6
Campinas 6
Francavilla di Sicilia 6
Haikou 6
Medellín 6
Milan 6
Nuremberg 6
Querétaro 6
Shenyang 6
Taizhou 6
Tokyo 6
Biên Hòa 5
Boardman 5
Chicago 5
Francofonte 5
Goiânia 5
Istanbul 5
Johannesburg 5
Manchester 5
Poplar 5
Porto Alegre 5
Portsmouth 5
Riposto 5
Seattle 5
Shanghai 5
Southampton 5
Ankara 4
Borghetto Santo Spirito 4
Brno 4
Cagliari 4
Totale 3.893
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of novel inhibitors of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense, as antitrypanosomal agents 342
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 190
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 184
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 168
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 159
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 157
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 155
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 151
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 150
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 149
Development of novel amides as non covalent inhibitors of immunoproteasome 148
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 147
Evaluation of curcumin irreversibility 146
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 143
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 141
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 138
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 136
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 136
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 135
Design, synthesis and biological evaluation of potent rhodesain inhibitors as antitrypanosomal agents 130
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 128
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 126
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 126
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 121
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 119
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 117
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 117
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 116
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 114
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 111
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 110
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 110
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 109
Monoclonal antibodies: the greatest resource to treat multiple myeloma 103
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 100
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 99
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 94
Neurotensin, a multi-faceted peptide 94
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 93
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 91
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 91
Falcipain-2 and Falcipain-3 inhibitors as promising antimalarial agents 89
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 88
Optimization of radiopharmaceuticals based on neurotensin[8-13] for NTS1-positive tumours imaging 88
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 88
Silicon-containing neurotensin analogues as radiopharmaceuticals for NTS1-positive tumors imaging 87
CAR-T cell therapy for prostate cancer: current advances and future perspectives 83
Design, synthesis, and in vitro characterization of proteolytically-stable opioid-neurotensin hybrid peptidomimetics 80
Optimized opioid-neurotensin multitarget peptides: from design to structure−activity relationship studies 80
Identification of dual inhibitors targeting main protease (Mpro) and cathepsin L as potential anti-SARS-CoV‑2 agents 79
Structure-based design of melanocortin 4 receptor ligands based on the SHU-9119-hMC4R cocrystal structure 78
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 77
Design and synthesis of opioid-neurotensin hybrid peptidomimetics: analgesics with reduced side effect profiles 74
Design, synthesis, and biological evaluation of the first radio-metalated neurotensin analogue targeting neurotensin receptor 2 74
Identification of constrained peptidomimetics carrying a Michael acceptor warhead as antitrypanosomal agents 69
Design and synthesis of 68Ga-labeled peptide-based heterodimers for dual targeting of NTS1 and GRPR 67
The inhibition of NS2B/NS3 protease: a new therapeutic opportunity to treat Dengue and Zika virus infection 65
Development of peptide-based SARS CoV-2 Mpro/hCatL dual inhibitors as antiviral agents 65
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 59
Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of Trypanosoma brucei rhodesiense 53
null 50
The role of nutraceuticals in chemoprevention and their therapeutic effects when used in combination with synthetic drugs 49
Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia 49
The Role of Nutraceuticals in Age-Related Ocular Diseases 39
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia 32
null 28
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management 22
null 22
null 22
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 20
Hybrid synthetic approach and biological characterization of a branched heterodimer for overcoming prostate cancer heterogeneity 20
Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics 17
N-Terminal stabilization of radiolabeled neurotensin analogues for improved tumor uptake 16
Supplement: 37th European Peptide Symposium 14th International Peptide Symposium August 25–August 29, 2024 | Florence, Italy 15
Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications 15
Inhibitors of proteases: a well-grounded strategy in drug development 15
Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease 13
Totale 7.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 23 8 7
2021/2022295 6 30 3 23 9 7 44 8 3 20 20 122
2022/2023981 62 94 42 77 55 103 47 78 364 4 48 7
2023/2024319 43 47 18 60 45 11 7 6 2 29 33 18
2024/20251.182 30 9 23 94 41 22 76 195 272 80 129 211
2025/20263.813 162 209 231 290 336 846 547 497 530 165 0 0
Totale 7.381